IL6 and gastric cancer: Given PPARα’s established role in restraining pro-inflammatory cytokines such as IL-6, IL-1β, and TNF-α [19], and the importance of inflammation in gastric cancer progression [20], we next assessed whether loss of PPARα elevates inflammatory mediators in GC cells.